Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "L01ED" (16)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Crizotinib (L01ED01) 5 products
WHO-DDD
L
IP
CI
PP
Xalkori 200 mg
60 Capsule(s)
3716.38
4058.20
10 %
Capsules: Crizotinibum 200 mg
Pfizer AG
A / SL
FB
G
L
IP
CI
PP
Xalkori 250 mg
60 Capsule(s)
4645.48
5068.65
10 %
Capsules: Crizotinibum 250 mg
Pfizer AG
A / SL
FB
G
IP
CI
Xalkori 20 mg
60
k.A.
filmüberzogenes Granulat zum Einnehmen: Crizotinibum 20 mg
Pfizer AG
A
FB
G
IP
Xalkori 50 mg
60
k.A.
filmüberzogenes Granulat zum Einnehmen: Crizotinibum 50 mg
Pfizer AG
A
FB
G
IP
Xalkori 150 mg
60
k.A.
filmüberzogenes Granulat zum Einnehmen: Crizotinibum 150 mg
Pfizer AG
A
FB
G
Ceritinib (L01ED02) 1 products
WHO-DDD
L
IP
CI
Zykadia
84
4003.77
4370.75
10 %
Coated tablets: Ceritinibum 150 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
Alectinib (L01ED03) 1 products
WHO-DDD
L
IP
CI
PP
Alecensa 150 mg
224
4344.43
4741.25
10 %
Capsules: Alectinibum 150 mg
Roche Pharma
(Schweiz) AG
A / SL
FB
G
Brigatinib (L01ED04) 7 products
WHO-DDD
L
IP
CI
Alunbrig 30 mg
28
722.39
802.05
10 %
Coated tablets: Brigatinibum 30 mg
Takeda Pharma AG
A / SL
FB
G
L
IP
CI
Alunbrig 90 mg
7
541.79
605.65
10 %
Coated tablets: Brigatinibum 90 mg
Takeda Pharma AG
A / SL
FB
G
L
IP
CI
Alunbrig 90 mg
28
2167.16
2373.35
10 %
Coated tablets: Brigatinibum 90 mg
Takeda Pharma AG
A / SL
FB
G
L
IP
CI
Alunbrig 180 mg
28
4334.31
4730.25
10 %
Coated tablets: Brigatinibum 180 mg
Takeda Pharma AG
A / SL
FB
G
L
IP
CI
Alunbrig 180 mg
7 + 21
4334.31
4730.25
10 %
Coated tablets: Brigatinibum 180 mg
Takeda Pharma AG
A / SL
FB
G
IP
CI
Alunbrig 30 mg
56
k.A.
Coated tablets: Brigatinibum 30 mg
Takeda Pharma AG
A
FB
G
IP
CI
Alunbrig 30 mg
112
k.A.
Coated tablets: Brigatinibum 30 mg
Takeda Pharma AG
A
FB
G
Lorlatinib (L01ED05) 2 products
WHO-DDD
L
IP
CI
Lorviqua 25 mg
90
3288.55
3592.90
10 %
Coated tablets: Lorlatinibum 25 mg
Pfizer AG
A / SL
FB
G
L
IP
CI
Lorviqua 100 mg
30
4384.73
4785.05
10 %
Coated tablets: Lorlatinibum 100 mg
Pfizer AG
A / SL
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
